Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Steve Sugarman"'
Autor:
Joy B. Ostroff, James A. H. Murray, Hannah Brewer, Carol R. Daniel, Nicole Onetto, Albert F. LoBuglio, Diane Healey, Mansoor N. Saleh, Donna LeBherz, Steve Sugarman, Dennie Jones
Publikováno v:
Journal of Clinical Oncology. 18:2282-2292
PURPOSE: We conducted a phase I clinical trial of BR96-Doxorubicin (BR96-Dox), a chimeric anti–Lewis Y (LeY) monoclonal antibody conjugated to doxorubicin, in patients whose tumors expressed the LeY antigen. The study aimed to determine the toxicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ae6a7271df3447c357b13c115403b08
https://doi.org/10.1200/jco.2000.18.11.2282
https://doi.org/10.1200/jco.2000.18.11.2282
Autor:
Mark E. Robson, Chau T. Dang, Diana Lake, Katherine S. Panageas, Arti Hurria, Mary Ellen Moynahan, Maura N. Dickler, Clifford A. Hudis, Theresa Gilewski, Karen Lisa Smith, Steve Sugarman, Larry Norton, Tiffany A. Troso-Sandoval, Monica Fornier, Nancy Mills, Gabriella D'Andrea, Roshini George
Publikováno v:
Clinical breast cancer. 8(5)
Purpose We conducted a pilot study of dose-dense epirubicin/cyclophosphamide (EC) × 6 → paclitaxel (P) × 6 with pegfilgrastim. A previous dose-dense trial of FEC (5-fluorouracil [5-FU]/EC) × 6 with filgrastim → by weekly paclitaxel alternating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a16bd59710be420d4d94870b08307c9b
https://pubmed.ncbi.nlm.nih.gov/18952555
https://pubmed.ncbi.nlm.nih.gov/18952555
Publikováno v:
Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2(4)
Three male industrial radiographers, two aged 40 and one aged63, performed a routine inspection of an industrial radiographydevice (IRD). During the course of the inspection, they observedthat the radioactive source (a 93.4 curie iridium-192 source)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b34999eb618eb9234849a55978f44c1
https://pubmed.ncbi.nlm.nih.gov/18072138
https://pubmed.ncbi.nlm.nih.gov/18072138
Autor:
James L. Abbruzzese, Dennie V. Jones, Scott M. Lippman, Steve Sugarman, Dennis F. Moore, Beth Bready, Richard Pazdur
Publikováno v:
American Journal of Clinical Oncology. 18:525-527
The combination of interferons (IFNs) and retinoids in antineoplastic therapy is based upon preclinical, in vitro, and in vivo observations. Retinoid-IFN combinations have shown significant antitumor activity against advanced cutaneous and cervical s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::637c10350229c1338b66f438cbfb2b43
https://doi.org/10.1097/00000421-199512000-00013
https://doi.org/10.1097/00000421-199512000-00013